| Home | Log In | Register | Our Services | My Account | Contact | Help |
- 29 Jan 2013 16:22
- 124 of 141
- 29 Jan 2013 16:30
- 125 of 141
- 29 Jan 2013 17:04
- 127 of 141
- 29 Jan 2013 19:38
- 128 of 141
- 29 Jan 2013 20:51
- 129 of 141
- 17 Apr 2013 07:47
- 130 of 141
- 27 Apr 2013 09:13
- 132 of 141
- 30 Apr 2013 20:06
- 133 of 141
- 25 Jul 2013 09:53
- 134 of 141
- 25 Jul 2013 19:04
- 135 of 141
- 10 Sep 2013 09:21
- 136 of 141
- 10 Sep 2013 19:47
- 137 of 141
- 23 Oct 2013 09:32
- 138 of 141
- 28 Oct 2013 17:11
- 140 of 141
- 08 Oct 2015 10:32
- 141 of 141
Shares Investor Evenings showcase up to four presentations from leading companies bringing them together in one room for one evening only.
Directors present their latest plans regarding development and growthAn opportunity to talk directly to the companies and personally put forward your questionsThe chance to network with other attendees over drinks and canapés - private investors, wealth managers, private client brokers, fund managers and financial institutionsWednesday 4th November 2015
Venue:Novotel Tower Bridge, London EC3N, 10 Pepys Street, London, EC3N 2NR
Event Timings:| 18.00 | Registration and coffee | |
| 18.30 | Presentations • Prof. Dr. Hermann Lübbert, CEO - Biofrontera (B8F) + More to be announced | |
| 20.30 | Drinks reception and canapés | |
| 21.30 | Close |
We specialize in dermatology, because the health of your skin is our profession. With our innovative products we would like to cure and protect your skin, while creating value for our investors. Biofrontera AG operates as an administrative holding company with four wholly-owned subsidiaries, Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, Biofrontera Development GmbH and Biofrontera Neuroscience GmbH. While the first two cover the operational business of Biofrontera group, the latter allow structured funding of individual clinical development projects. The companies occupy fully equipped, modern lab facilities with sufficient space for growth, an own GMP-certified laboratory and a GMP-certified medicament storage room.Biofrontera group was founded in 1997 by Prof. Dr. Hermann Lübbert, the current CEO, and is located in Leverkusen, Germany. Since 2006 Biofrontera is listed in the regulatory market under the ISIN DE0006046113, the company currently employs 46 people. |
Magnolia Petroleum plc is an AIM quoted oil and gas production company focused on the acquisition, exploitation and development of oil and gas properties primarily located onshore in the United States. Led by a highly skilled management team with over 100 years combined experience in the onshore oil and gas industry, the Company already has interests in approximately 183+ producing properties and over 13,500 net mineral acres in two major project areas, the potentially game-changing and highly productive Bakken shale in North Dakota and the proven Woodford/Mississippi and Hunton formations in Oklahoma. |